NR566 WEEK 8 FINAL EXAM COMPLETE TEST
BANK ACTUAL PRACTICE QUESTIONS,
ANSWERS & EXPERT RATIONALES ADVANCED
PHARMACOLOGY FOR CARE OF THE FAMILY
CHAMBERLAIN UNIVERSITY GRADED A+
PREMIUM STUDY BUNDLE
Unlock an A+ on your final exam with this premium,
comprehensive test bank featuring 200 high-yield multiple-
choice questions for NR566 Advanced Pharmacology for
Care of the Family. Each question is immediately paired with
its correct answer and an expert-verified, bold-italicized
clinical rationale analyzing women's health, psychotropic
agents, and guideline-directed family therapies. Perfect for
last-minute cramming or systematic review, this digital
download is specifically structured to mirror actual
Examplify proctored testing parameters and maximize your
performance.
Q1. A 52-year-old postmenopausal female with an intact uterus
requests hormone replacement therapy (HRT) for severe vasomotor
,symptoms. Which of the following regimens is the safest and most
appropriate choice?
A) Oral estradiol monotherapy
B) Transdermal estradiol combined with a progestin
C) Oral conjugated equine estrogens monotherapy
D) High-dose testosterone therapy
• Answer: B
• Rationale: In women with an intact uterus, systemic estrogen
therapy must always be paired with a progestin to prevent
endometrial hyperplasia and significantly reduce the risk of
endometrial cancer.
Q2. A clinician is prescribing transdermal estradiol patches to a
patient experiencing menopause. What is a primary clinical advantage
of transdermal estrogen administration over oral administration?
A) Complete avoidance of protein binding
B) Lower risk of deep vein thrombosis due to bypassing first-pass hepatic
metabolism
C) Higher rates of uterine tissue regeneration
D) Increased absorption in patients with high body mass index
• Answer: B
• Rationale: Transdermal estrogen bypasses first-pass hepatic
metabolism, resulting in a lower risk of thromboembolic events
(DVT/PE) and stroke compared to oral formulations.
Q3. A 48-year-old female presents with irregular, heavy menstrual
bleeding. The clinician decides to initiate a temporary course of
progestin therapy. What is the standard duration of progestin
administration required each month to treat dysfunctional uterine
bleeding?
A) 2 to 4 days
B) 5 to 7 days
,C) 10 to 14 days
D) 25 to 28 days
• Answer: C
• Rationale: A progestin course of 10 to 14 days minimum each
month is required to mimic the natural luteal phase, stop
endometrial proliferation, and induce a predictable withdrawal
bleed.
Q4. A 62-year-old female patient is prescribed Raloxifene (Evista) for
the prevention of postmenopausal osteoporosis. How does this
selective estrogen receptor modulator (SERM) behave in breast and
bone tissues?
A) Agonist in breast, antagonist in bone
B) Antagonist in breast, agonist in bone
C) Agonist in both breast and bone
D) Antagonist in both breast and bone
• Answer: B
• Rationale: Raloxifene acts as an estrogen agonist in bone tissue
to preserve bone mineral density, but functions as an estrogen
antagonist in breast and uterine tissue, reducing breast cancer
risks.
Q5. A 17-year-old female with severe, scarring nodulocystic acne has
failed topicals and oral tetracyclines. The provider considers oral
Isotretinoin. Which program mandatory registration must be
completed before prescribing?
A) REMS Combat Methamphetamine Act
B) iPLEDGE Program
C) STEP Risk Mitigation
D) DEA Schedule II Authorization
• Answer: B
, • Rationale: Isotretinoin is highly teratogenic. The iPLEDGE
program is a strict, mandatory registry requiring regular
negative pregnancy tests and two distinct forms of
contraception for females of childbearing potential.
Q6. A patient taking oral Isotretinoin for severe acne requires close
laboratory monitoring. Which baseline and periodic laboratory panels
are most critical to follow during treatment?
A) Renal function and serum potassium
B) Liver function tests (LFTs) and fasting lipid panels
C) Complete blood counts and thyroid stimulating hormone
D) Prothrombin time and international normalized ratio
• Answer: B
• Rationale: Isotretinoin is metabolized by the liver and can cause
significant hypertriglyceridemia and elevations in transaminases
(ALT/AST), requiring steady lab tracking.
Q7. A patient presents with severe seasonal allergic rhinitis that
impairs daily functioning. Which drug class stands as the single most
effective first-line therapy for preventing and relieving all symptoms
of allergic rhinitis?
A) Oral first-generation antihistamines
B) Intranasal glucocorticoids
C) Oral leukotriene receptor antagonists
D) Mast cell stabilizers
• Answer: B
• Rationale: Intranasal corticosteroids (glucocorticoids) are the
most potent and comprehensive first-line treatment for allergic
rhinitis, suppressing multiple inflammatory mediators.
Q8. When evaluating the clinical efficacy of Selective Serotonin
Reuptake Inhibitors (SSRIs) versus Serotonin-Norepinephrine
Reuptake Inhibitors (SNRIs) for Major Depressive Disorder (MDD),
which statement is true?
BANK ACTUAL PRACTICE QUESTIONS,
ANSWERS & EXPERT RATIONALES ADVANCED
PHARMACOLOGY FOR CARE OF THE FAMILY
CHAMBERLAIN UNIVERSITY GRADED A+
PREMIUM STUDY BUNDLE
Unlock an A+ on your final exam with this premium,
comprehensive test bank featuring 200 high-yield multiple-
choice questions for NR566 Advanced Pharmacology for
Care of the Family. Each question is immediately paired with
its correct answer and an expert-verified, bold-italicized
clinical rationale analyzing women's health, psychotropic
agents, and guideline-directed family therapies. Perfect for
last-minute cramming or systematic review, this digital
download is specifically structured to mirror actual
Examplify proctored testing parameters and maximize your
performance.
Q1. A 52-year-old postmenopausal female with an intact uterus
requests hormone replacement therapy (HRT) for severe vasomotor
,symptoms. Which of the following regimens is the safest and most
appropriate choice?
A) Oral estradiol monotherapy
B) Transdermal estradiol combined with a progestin
C) Oral conjugated equine estrogens monotherapy
D) High-dose testosterone therapy
• Answer: B
• Rationale: In women with an intact uterus, systemic estrogen
therapy must always be paired with a progestin to prevent
endometrial hyperplasia and significantly reduce the risk of
endometrial cancer.
Q2. A clinician is prescribing transdermal estradiol patches to a
patient experiencing menopause. What is a primary clinical advantage
of transdermal estrogen administration over oral administration?
A) Complete avoidance of protein binding
B) Lower risk of deep vein thrombosis due to bypassing first-pass hepatic
metabolism
C) Higher rates of uterine tissue regeneration
D) Increased absorption in patients with high body mass index
• Answer: B
• Rationale: Transdermal estrogen bypasses first-pass hepatic
metabolism, resulting in a lower risk of thromboembolic events
(DVT/PE) and stroke compared to oral formulations.
Q3. A 48-year-old female presents with irregular, heavy menstrual
bleeding. The clinician decides to initiate a temporary course of
progestin therapy. What is the standard duration of progestin
administration required each month to treat dysfunctional uterine
bleeding?
A) 2 to 4 days
B) 5 to 7 days
,C) 10 to 14 days
D) 25 to 28 days
• Answer: C
• Rationale: A progestin course of 10 to 14 days minimum each
month is required to mimic the natural luteal phase, stop
endometrial proliferation, and induce a predictable withdrawal
bleed.
Q4. A 62-year-old female patient is prescribed Raloxifene (Evista) for
the prevention of postmenopausal osteoporosis. How does this
selective estrogen receptor modulator (SERM) behave in breast and
bone tissues?
A) Agonist in breast, antagonist in bone
B) Antagonist in breast, agonist in bone
C) Agonist in both breast and bone
D) Antagonist in both breast and bone
• Answer: B
• Rationale: Raloxifene acts as an estrogen agonist in bone tissue
to preserve bone mineral density, but functions as an estrogen
antagonist in breast and uterine tissue, reducing breast cancer
risks.
Q5. A 17-year-old female with severe, scarring nodulocystic acne has
failed topicals and oral tetracyclines. The provider considers oral
Isotretinoin. Which program mandatory registration must be
completed before prescribing?
A) REMS Combat Methamphetamine Act
B) iPLEDGE Program
C) STEP Risk Mitigation
D) DEA Schedule II Authorization
• Answer: B
, • Rationale: Isotretinoin is highly teratogenic. The iPLEDGE
program is a strict, mandatory registry requiring regular
negative pregnancy tests and two distinct forms of
contraception for females of childbearing potential.
Q6. A patient taking oral Isotretinoin for severe acne requires close
laboratory monitoring. Which baseline and periodic laboratory panels
are most critical to follow during treatment?
A) Renal function and serum potassium
B) Liver function tests (LFTs) and fasting lipid panels
C) Complete blood counts and thyroid stimulating hormone
D) Prothrombin time and international normalized ratio
• Answer: B
• Rationale: Isotretinoin is metabolized by the liver and can cause
significant hypertriglyceridemia and elevations in transaminases
(ALT/AST), requiring steady lab tracking.
Q7. A patient presents with severe seasonal allergic rhinitis that
impairs daily functioning. Which drug class stands as the single most
effective first-line therapy for preventing and relieving all symptoms
of allergic rhinitis?
A) Oral first-generation antihistamines
B) Intranasal glucocorticoids
C) Oral leukotriene receptor antagonists
D) Mast cell stabilizers
• Answer: B
• Rationale: Intranasal corticosteroids (glucocorticoids) are the
most potent and comprehensive first-line treatment for allergic
rhinitis, suppressing multiple inflammatory mediators.
Q8. When evaluating the clinical efficacy of Selective Serotonin
Reuptake Inhibitors (SSRIs) versus Serotonin-Norepinephrine
Reuptake Inhibitors (SNRIs) for Major Depressive Disorder (MDD),
which statement is true?
